Global Life Sciences Solutions USA LLC

Cytiva is a global leader in bioprocessing technologies, tools, and services for biopharmaceutical manufacturing. The company specializes in modular biologics manufacturing platforms (KUBio, FlexFactory) designed to meet cGMP standards and deployable in approximately 18 months. Core offerings include chromatography resins, single-use technologies, and downstream/upstream processing solutions for vaccine development, monoclonal antibodies (mAbs), mRNA therapeutics, cell therapy, and viral vector manufacturing. Cytiva provides comprehensive support across the biopharmaceutical value chain: process development services (Fast Trak), bioprocessing digital tools, regulatory compliance resources, training programs, and technical documentation. The company emphasizes sustainability through eco-design and circular economy practices, and actively collaborates with research institutions and contract manufacturers globally to advance next-generation therapeutic platforms including gene therapy, CAR-T cell therapies, and biosimilars.